Drug
Eltanexor
Eltanexor: highest development phase Phase 1, developed by Karyopharm Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Karyopharm Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Eltanexor NCT06399640 | Phase 1 | Relapsed Myelodysplastic Syndrome |
Latest
No recent events.
Follow Eltanexor on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.